Zucker Stanley, Schmidt Cathleen E, Dufour Antoine, Kaplan Robert C, Park Hyun I, Jiang Weiping
Department of Research, Veterans Affairs Medical Center, Northport, New York 11768, USA.
Connect Tissue Res. 2009;50(4):223-31. doi: 10.1080/03008200802626970.
Activation of MMPs in tissues is an important component of tissue injury. Based on earlier reports that (latent) proMMP-2 is incapable of forming a complex with TIMP-1, we reasoned that the identification of MMP-2:TIMP-1 complexes in blood might serve as a surrogate marker ("smoking gun") of MMP-2 activation in tissues. Using specific antibodies, we developed a sensitive and specific assay to detect MMP-2:TIMP-1 complexes. We were perplexed to find that approximate 40% of plasma specimens from healthy individuals had detectable levels of the MMP-2:TIMP-1 complexes. Employing recombinant TIMP-1 bound Sepharose beads and Western blots, we demonstrated binding between recombinant proMMP-2 and TIMP-1 proteins. Recombinant MMP-2 lacking the catalytic domain also bound to TIMP-1 coated beads. These data are consistent with TIMP-1 binding to the hemopexin or hinge domain of proMMP-2. The explanation for the presence of plasma proMMP-2:TIMP-1 complexes in selected healthy individuals remains to be determined. In contrast to our immunoassay and bead-binding experiments, proMMP-2 failed to bind to immobilized TIMP-1 employing surface plasmon resonance technology. Additional studies are needed to clarify these contrasting results.
组织中基质金属蛋白酶(MMPs)的激活是组织损伤的一个重要组成部分。基于早期报告称(潜伏性)前MMP-2无法与组织金属蛋白酶抑制剂-1(TIMP-1)形成复合物,我们推断血液中MMP-2:TIMP-1复合物的鉴定可能作为组织中MMP-2激活的替代标志物(“确凿证据”)。我们使用特异性抗体开发了一种灵敏且特异的检测方法来检测MMP-2:TIMP-1复合物。我们惊讶地发现,约40%健康个体的血浆标本中可检测到MMP-2:TIMP-1复合物水平。利用重组TIMP-1结合琼脂糖珠和蛋白质印迹法,我们证实了重组前MMP-2与TIMP-1蛋白之间的结合。缺乏催化结构域的重组MMP-2也能与包被有TIMP-1的珠子结合。这些数据与TIMP-1结合到前MMP-2的血色素结合蛋白或铰链结构域一致。选定健康个体血浆中存在前MMP-2:TIMP-1复合物的原因仍有待确定。与我们的免疫测定和珠子结合实验不同,利用表面等离子体共振技术,前MMP-2无法与固定化的TIMP-1结合。需要进一步研究来阐明这些相互矛盾的结果。